$1.85
-0.0400 (-2.12%)
At Close: Jun 03, 2026
Swimming: Fina World Cup Singapore leg in September cancelled due to Covid-19
05:44am, Monday, 27'th Jul 2020
SINGAPORE - The Singapore leg of the Fina Swimming World Cup, scheduled for Sept 4-6, is the latest sporting event here to be cancelled as a result of the coronavirus pandemic.. Read more at straitsti
5 Value Stocks In The Healthcare Sector
12:00am, Monday, 27'th Jul 2020
What are Value Stocks?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E...
Social Security: 10 Smart Ways to Get More Benefits | The Motley Fool
04:04pm, Sunday, 26'th Jul 2020
Armed with some key information, you may be able to make smarter Social Security decisions -- and collect more money.
How Coronavirus Stimulus Checks Impact SSI Benefits in Tampa, FL - Carrollwood, FL Patch
05:30pm, Friday, 24'th Jul 2020
Check out the latest community post from one of your neighbors. (The views expressed in this post are the author’s own.)
Congress needs to revitalize the Supplemental Security Income program for the elderly
03:30pm, Thursday, 23'rd Jul 2020
The program suffers from administrative problems that, in the COVID-19 environment, are going to accelerate quickly.
Lexicon Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call and Webcast on July 30, 2020
11:00am, Thursday, 23'rd Jul 2020
THE WOODLANDS, Texas, July 23, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its second quarter 2020 financial results on Thursday, July 30, 2020 before market op
Earnings Preview: Lexicon Pharmaceuticals (LXRX) Q2 Earnings Expected to Decline
04:32pm, Wednesday, 22'nd Jul 2020
Lexicon (LXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biohaven's Phase 3 Trial, And Other News: The Good, Bad And Ugly Of Biopharma
04:03pm, Wednesday, 22'nd Jul 2020
Biohaven completes enrollment in Phase 3 clinical trial for Multiple System Atrophy. Lexicon Pharma reports positive late stage studies data.
Facebook’s Connectivity Investments to grow Africa’s economy by $57 billion in 5 years
03:14pm, Wednesday, 22'nd Jul 2020
By Funmilola Gboteku Lagos, July 22, 2020 American social media conglomerate, Facebook, on Wednesday said that its connectivity investment would grow Africa’s economy by 57 billion dollars in the n�
Facebook’s Connectivity Investments to grow Africa’s economy by $57 billion in 5 years ⋆
01:05pm, Wednesday, 22'nd Jul 2020
American social media conglomerate, Facebook, on Wednesday said that its connectivity investment would grow Africa’s economy by 57 billion dollars in the next five years.
Some Retirees Are Missing Out on Millions of Dollars in Social Security Benefits. Here's Why -- and What to Do About It | The Motley Fool
10:02am, Wednesday, 22'nd Jul 2020
Are you one of them?
IPO Update: Nurix Therapeutics Prepares IPO Terms
03:55pm, Tuesday, 21'st Jul 2020
Nurix Therapeutics has filed to raise $150 million in a U.S. IPO.
Former spy boss Arthur Fraser threatens to dish secrets at state capture inquiry
01:49pm, Tuesday, 21'st Jul 20203 Ways a Recession Could Affect Social Security and Your Retirement | The Motley Fool
01:09pm, Tuesday, 21'st Jul 2020
As you're planning for retirement, be sure you've thought about how the recession could affect your senior years.
Lexicon Pharmaceuticals Announces Topline Phase 3 Data From Four Phase 3 Sotagliflozin Studies in Type 2 Diabetes
11:00am, Tuesday, 21'st Jul 2020
THE WOODLANDS, Texas, July 21, 2020 -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced topline data from four Phase 3 sotagliflozin studies in type 2 diabetes:.
Sign In
Buy LXRX